Search research articles
Contact Us
Filters
Showing results (71-80 of 110) with videos related to
Page
of 11
Sort By:
Circulation. Heart Failure
|
March 12, 2021
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF Analysis
Luis E Rohde, Brian L Claggett, Emil Wolsk, et al.
Circulation. Cardiovascular Quality and Outcomes
|
March 24, 2021
Socioeconomic Status and Outcomes in Heart Failure With Reduced Ejection Fraction From Asia
Tiew-Hwa K Teng, Wan Ting Tay, Arthur Mark Richards, et al.
JACC. Heart Failure
|
April 28, 2022
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial
Maja Cikes, Ivo Planinc, Brian Claggett, et al.
ESC Heart Failure
|
May 9, 2020
Ethnic differences in atrial fibrillation among patients with heart failure in Asia
Eugene S J Tan, Vera Goh, Bernadet T Santema, et al.
Plos Medicine
|
September 25, 2019
Association of obesity with heart failure outcomes in 11 Asian regions: A cohort study
Chanchal Chandramouli, Wan Ting Tay, Nurul Sahiddah Bamadhaj, et al.
European Heart Journal
|
August 10, 2016
Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry
Carolyn S P Lam, Tiew-Hwa Katherine Teng, Wan Ting Tay, et al.
Circulation. Heart Failure
|
April 18, 2018
Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial
Eldrin F Lewis, Brian Claggett, Amil M Shah, et al.
JACC. Heart Failure
|
March 14, 2014
Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure)
Mark Richards, Salvatore Di Somma, Christian Mueller, et al.
JAMA Cardiology
|
October 13, 2021
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial
G Michael Felker, Scott D Solomon, Brian Claggett, et al.
JACC. Asia
|
June 16, 2023
Patient-Reported Status and Heart Failure Outcomes in Asia by Sex, Ethnicity, and Socioeconomic Status
Claire A Lawson, Wan Ting Tay, Mark Richards, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 110) with videos related to
Sort By:
Page
of 11
Circulation. Heart Failure
|
March 12, 2021
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF Analysis
Luis E Rohde, Brian L Claggett, Emil Wolsk, et al.
Circulation. Cardiovascular Quality and Outcomes
|
March 24, 2021
Socioeconomic Status and Outcomes in Heart Failure With Reduced Ejection Fraction From Asia
Tiew-Hwa K Teng, Wan Ting Tay, Arthur Mark Richards, et al.
JACC. Heart Failure
|
April 28, 2022
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial
Maja Cikes, Ivo Planinc, Brian Claggett, et al.
ESC Heart Failure
|
May 9, 2020
Ethnic differences in atrial fibrillation among patients with heart failure in Asia
Eugene S J Tan, Vera Goh, Bernadet T Santema, et al.
Plos Medicine
|
September 25, 2019
Association of obesity with heart failure outcomes in 11 Asian regions: A cohort study
Chanchal Chandramouli, Wan Ting Tay, Nurul Sahiddah Bamadhaj, et al.
European Heart Journal
|
August 10, 2016
Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry
Carolyn S P Lam, Tiew-Hwa Katherine Teng, Wan Ting Tay, et al.
Circulation. Heart Failure
|
April 18, 2018
Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial
Eldrin F Lewis, Brian Claggett, Amil M Shah, et al.
JACC. Heart Failure
|
March 14, 2014
Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure)
Mark Richards, Salvatore Di Somma, Christian Mueller, et al.
JAMA Cardiology
|
October 13, 2021
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial
G Michael Felker, Scott D Solomon, Brian Claggett, et al.
JACC. Asia
|
June 16, 2023
Patient-Reported Status and Heart Failure Outcomes in Asia by Sex, Ethnicity, and Socioeconomic Status
Claire A Lawson, Wan Ting Tay, Mark Richards, et al.
Page
of 11